Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 9/2015

01-09-2015 | Retraction Note

Retraction Note to: relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis

Authors: Wei-Zhong Xiao, Dong-Hua Han, Fei Wang, Yong-Qian Wang, You-Hou Zhu, Yi-Fang Wu, Ning-Tao Liu, Ji-Yong Sun

Published in: Tumor Biology | Issue 9/2015

Login to get access

Excerpt

Retraction to: Tumor Biol. (2014) 35:6687–6693 …
Metadata
Title
Retraction Note to: relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis
Authors
Wei-Zhong Xiao
Dong-Hua Han
Fei Wang
Yong-Qian Wang
You-Hou Zhu
Yi-Fang Wu
Ning-Tao Liu
Ji-Yong Sun
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3715-5

Other articles of this Issue 9/2015

Tumor Biology 9/2015 Go to the issue

Research Article

A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer

Research Article

Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma

Research Article

Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma

Research Article

MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells

Research Article

Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma

Retraction Note

Retraction Note to: Correlation between PARP-1 Val762Ala polymorphism and the risk of lung cancer in a Chinese population
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits